From May 17 to 18, the Economic Committee of the Provincial CPPCC went to Baiyin City to carry out the pilot research of "Provincial CPPCC to help Baiyin City's high-quality economic and social development".

The research team went to our company to guide the work, Mr. Wang Linshan, deputy general manager of Baiyinkang Yuxin Biotechnology Co., Ltd. made a detailed report on the situation of the enterprise, and the provincial leaders understood the company's industrial development, project construction progress, business environment and enterprise production and operation.

The research team believes that at present, silver is in an important window period of transformation and development, the advantages are more prominent, the economic development continues to improve, the industrial upgrading foundation is solid, the momentum of vitality is growing, and the entrepreneurial atmosphere is stronger, creating a good foundation and favorable conditions for promoting high-quality development in an all-round way. Baiyin City should take the high-quality economic and social development as an opportunity, pay close attention to industrial development, integrate the forces of all aspects, timely discover and solve the major problems in the industrial chain extension and reinforcement chain, scientifically grasp the rhythm and steps, and strive to improve and achieve breakthroughs

Kang Yu Xin biological

       Kangyuxin Biotechnology Co., Ltd. was established in October 2013, specializing in the research and development, production, sales and related service technology development of pyrazine intermediates and process libraries. Kangyuxin has more than 2,000 square meters of standardized laboratories, with an output value of more than 80 million yuan in 2022. The core technology of pyrazine derivatives of Kangyuxin ranks the leading level in China, and the varieties and orders of pyrazine series products are ranked first in the domestic industry. Kangyuxin has an experienced and high-quality drug process research and development team, which can realize the research and development and process production from lead compounds to clinical batch apis. Kangyuxin Drug Quality research team can provide effective data and method validation for drug registration and research.

        The company was supported by the innovation Fund of Gansu Province in 2016, and was identified as the first batch of provincial science and technology innovation enterprises by the Department of Science and Technology of Gansu Province, and has been supported by the science and technology innovation Fund of Lanzhou and Baiyin for many times. Wang Youwei, the founder of the company, was named "One hundred innovative and entrepreneurial models in Lanzhou City" in 2015. Kangyuxin, as the first domestic enterprise to develop a broad spectrum antiviral new drug "Fapiravir", was shortlisted in the eighth batch of key protection enterprises for epidemic prevention materials in Gansu Province. Kangyuxin won the Excellence Award of the 10th China Innovation and Entrepreneurship Competition National Biomedical Industry Competition in 2021 (the second place in the group), and the second place in the Gansu Division of the 10th China Innovation and Entrepreneurship Competition. Won the first prize in the Northwest region of the 2020 "Guotong Cup" Lanzhou University Global Alumni Entrepreneurship Competition, and the first prize of the Baiyin Double Innovation Competition for two consecutive years in 2020 and 2021. In 2022, it will be evaluated as a high-tech enterprise and a specialized and special new enterprise.